Avista Pharma Solutions Hires Eric Kesslen As Site Director Of Their Massachusetts Facility
Expert in Pharmaceutical Product Testing Will Oversee Company’s Microbiology and Analytical Growth Strategy
AGAWAM, Mass., May 31, 2017 – Avista Pharma Solutions, Inc. (“Avista Pharma”) today announced the hiring of Eric Kesslen as site director of the Agawam, Massachusetts facility. In his role, Dr. Kesslen will oversee the company’s operational and support groups associated with the analytical, microbiological and cleanroom services offered by Avista Pharma Solutions.
Dr. Kesslen has 19 years of experience working in analytical product development and microbiology laboratories supporting all phases of pharmaceutical product development. He has held leadership roles in the implementation of quality management systems, ERP systems and electronic document control systems and managed in high growth environments.
Since 1998, Dr. Kesslen has held roles of increasing responsibility in the analytical development, stability and compendial testing laboratories at AAIPharma Services. In these positions, he was a change agent driving the company’s key global initiatives. Specifically, he was responsible for operations oversight, fiscal policy, strategic planning of business development and capital equipment acquisition.
Dr. Kesslen received his bachelor’s degree in chemistry from Arizona State University and his master’s and doctorate degrees in inorganic chemistry from the University of Rhode Island. Dr. Kesslen has been published in the Journal of Pharmaceutical and Biomedical Analysis, Chemistry of Materials, Tetrahedron Letters and Polyhedron.
“Eric Kesslen is an industry expert with experience in leading agile, high growth businesses,” said Pat Walsh, CEO of Avista Pharma. “He is a great addition to our experienced leadership team and will compliment Avista Pharma’s exceptional scientific and technical capabilities.”
NEW MEDIA CONTENT:
Avista Pharma on Facebook
Avista Pharma on Twitter
Avista Pharma on LinkedIn
About Avista Pharma Solutions, Inc.:
Avista Pharma, a portfolio company of Ampersand Capital Partners, is a contract testing, development and manufacturing organization (CDMO) encompassing more than 200,000 square feet of laboratory and manufacturing space across three locations (Agawam, Massachusetts; Durham, North Carolina and Longmont, Colorado), providing pharmaceutical, animal health and medical device clients a broad suite of scientifically-differentiated services, ranging from early stage API and Drug Product discovery, development and cGMP manufacturing, to standalone analytical and microbiology testing support. For more information about Avista Pharma Solutions, Inc., please visit us at www.avistapharma.com.